Physiotherapy and cardiac rhythm devices: A review of the current scope of practice

Europace

Volumn 11, Issue 7, 2009, Pages 850-859

  Digby, Genevive C ^a   Daubney, Marguerite E ^b   Baggs, Jim ^b   Campbell, Debra ^a   Simpson, Christopher S ^a   Redfearn, Damian P ^a   Brennan, F James ^a   Abdollah, Hoshiar ^a   Baranchuk, Adrian ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b Blaser's Physiotherapy and Acupuncture Clinic   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUPUNCTURE; ARTIFICIAL HEART PACEMAKER; DEFIBRILLATOR; DIATHERMY; HEART ARRHYTHMIA; HUMAN; LOW LEVEL LASER THERAPY; MANIPULATIVE MEDICINE; PATIENT SAFETY; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; TRANSCUTANEOUS NERVE STIMULATION; ULTRASOUND THERAPY;

DEFIBRILLATORS, IMPLANTABLE; EQUIPMENT FAILURE; EQUIPMENT SAFETY; INTERNATIONALITY; PACEMAKER, ARTIFICIAL; PHYSICAL THERAPY MODALITIES; PRACTICE GUIDELINES AS TOPIC;

EID: 67650869759     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup102     Document Type: Review

References (29)

1. Eriksson M, Schüller H, Sjölund B. Hazards from transcutaneous nerve stimulation in patients with pacemakers. Lancet 1978;1:1319.
2. Rasmussen MJ, Hayes DL, Vliestra RE et al. Can transcutaneous electrical nerve stimulation be safely used in patients with permanent pacemakers? Mayo Clin Proc 1988;63:443-5.
3. Vlay SC. Electromagnetic interference and ICD discharge related to chiropractic treatment. Pacing Clin Electrophysiol 1998;21:1996-8.
4. Baranchuk A, Morillo CA. Guidelines for the prevention of sudden cardiac death: filling the gap. In Gulizia M (ed.), In Emerging Pathologies in Cardiology. Milan: Springer; 2005. p223-30.
5. Anonymous. A comparison of antiarrhythmic-drug therapy with implantable defi-brillators in patients resuscitated from near-fatal ventricular arrhythmias. The Antiarrhythmics versus Implantable Defibrillators (AVID) Investigators. N Engl J Med 1997;337:1576-83.
6. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-83.
7. Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005;352:225-37.
8. Shields N, Gormley J, O'Hare N. Contraindications to continuous and pulsed short-wave diathermy. Phys Ther Rev 2002;7:133-43.
9. Holmgren C, Carlsson T, Mannheimer C, Edvardsson N. Risk of interference from transcutaneous electrical nerve stimulation on the sensing function of implantable defibrillators. Pacing Clin Electrophysiol 2008;31:151-8.
10. Medtronic Electromagnetic Compatibility Table For Pacemakers and Defibrilla-tors (ICD). Metronic, Inc.; 2004 Accessed 12 July 2008, at https:// www.medtronic.com.
11. Apaloo F. An acupuncture complication. Acupunct Med 1996;14:41.
12. Chen FP, Hwang SJ, Lee HP, Yang HY, Chung C. Clinical study of syncope during acupuncture treatment. Acupunct Electrother Res 1990;15:107-19.
13. Jones SL. Electromagnetic field interference and cardiac pacemakers. Phys Ther 1976;56:1013-8.
14. Valtonen EJ, Lilius HG, Tiula E. Disturbances in the function of cardiac pacemakers caused by short wave and microwave diathermies and pulsed high frequency current. Ann Chir Gynaecol Fenniae 1975;64:284-7.
15. Vergassola R, Borgioli A, Chiodi L, Rossi D, Fazi A, Lebrun E et al. Changes in pacemakers and the wearers of pacemakers as a result of the use of different electromagnetic energy sources. Minerva Cardioangiol 1994;42:27-32.
16. Delpizzo V, Joyner K. On the safe use of microwave and shortwave diathermy units. Aust J Physiother 1987;33:152-62.
17. Warning on Diathermy and Implanted Leads: FDA Patient Safety News: Show #13, March 2003. Accessed 08 February 2009, http://www.accessdata.fda.gov/ scripts/cdrh/cfdocs/psn/printer.cfm?id=22.
18. Beckerman H, de Bie RA, Bouter LM, DeCuyper HJ, Oostendorp RAB. The efficacy of laser therapy for musculoskeletal and skin disorders: a criteria-based meta-analysis or randomized clinical trials. Phys Ther 1992;72:483-9.
19. Volkman H. Interference of implanted pacemaker in medical practice. Herzschritt-macherther Elektrophysiol 2004;15:65-72.
20. Sluka KA, Walsh D. Transcutaneous electrical nerve stimulation: basic science mechanisms and clinical effectiveness. J Pain 2003;4:109-21.
21. Pinski SL, Trohman RG. Interference in implanted cardiac devices, part II. Pacing Clin Electrophysiol 2002;25:1496-509.
22. Chen D, Philip M, Philip PA et al. Cardiac pacemaker inhibition by transcutaneous electrical nerve stimulation. Arch Phys Med Rehabil 1990;71:27-30.
23. Philbin DM, Marieb MA, Aithal KH, Schoenfeld MH. Inappropriate shocks delivered by an ICD as a result of sensed potentials from a transcutaneous electronic nerve stimulation unit. Pacing Clin Electrophysiol 1999;22:400-1.
24. Crevenna R, Stix G, Pleiner J et al. Electromagnetic interference by transcu-taneous neuromuscular electrical stimulation in patients with bipolar sensing implantable cardioverter defibrillators: a pilot safety study. Pacing Clin Electrophysiol 2003;26:626-9.
25. Siu CW, Tse HF, Lau CP. Inappropriate implantable cardioverter defibrillator shock from a transcutaneous muscle stimulation device therapy. J Interv Card Elec-trophysiol 2005;13:73-5.
26. Pyatt JR, Trenbath D, Chester M, Connelly DT. The simultaneous use of a biven-tricular implantable cardioverter defibrillator (ICD) and transcutaneous electrival nerve stimulation (TENS) unit: implications for device interaction. Europace 2003; 5:91-3.
27. Occhetta E, Bortnik M, Magnani A, Francalacci G, Marino P. Inappropriate implan-table cardioverter-defibrillator discharges unrelated to supraventricular tachyar-rhythmias. Europace 2006;8:863-9.
28. Robertson VJ, Chipchase LS, Laakso EL, Whelan KM, McKenna LJ. Guidelines for the Clinical Use of Electrophysical Agents. Victoria: Australian Physiotherapy Association; 2001.
29. Campbell D, Bally K, Squires M. Radiation therapy in patients with cardiac rhythm devices: Minimizing the risk. Can J Cardiol 2007;23:NP14.